The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 04, 2025

Filed:

Mar. 03, 2022
Applicants:

Ayman S. El-baz, Louisville, KY (US);

Ahmed Shalaby, Louisville, KY (US);

Mohamed Elsharkawy, Louisville, KY (US);

Ahmed Sharafeldeen, Louisville, KY (US);

Ahmed Soliman, Louisville, KY (US);

Ali Mahmoud, Louisville, KY (US);

Harpal Sandhu, Louisville, KY (US);

Guruprasad A. Giridharan, Louisville, KY (US);

Inventors:

Ayman S. El-Baz, Louisville, KY (US);

Ahmed Shalaby, Louisville, KY (US);

Mohamed Elsharkawy, Louisville, KY (US);

Ahmed Sharafeldeen, Louisville, KY (US);

Ahmed Soliman, Louisville, KY (US);

Ali Mahmoud, Louisville, KY (US);

Harpal Sandhu, Louisville, KY (US);

Guruprasad A. Giridharan, Louisville, KY (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G06T 7/11 (2017.01); G06T 7/149 (2017.01); G16H 50/20 (2018.01); G16H 50/50 (2018.01);
U.S. Cl.
CPC ...
G06T 7/11 (2017.01); G06T 7/149 (2017.01); G16H 50/20 (2018.01); G16H 50/50 (2018.01); G06T 2207/10081 (2013.01); G06T 2207/20081 (2013.01); G06T 2207/20084 (2013.01); G06T 2207/30061 (2013.01);
Abstract

Assessment of pulmonary function in coronavirus patients includes use of a computer aided diagnostic (CAD) system to assess pulmonary function and risk of mortality in patients with coronavirus disease 2019 (COVID-19). The CAD system processes chest X-ray data from a patient, extracts imaging markers, and grades disease severity based at least in part on the extracted imaging markers, thereby distinguishing between higher risk and lower risk patients.


Find Patent Forward Citations

Loading…